Clive Morris

Dxterity Diagnostics, Inc. develops simple and affordable genomic testing solutions for the research, diagnostic, and therapeutic markets. It offers direct to patient platform, digital recruitment, genomic services, and QSR product development. The company was founded by Robert Terbrueggen and Jim Healy in 2006 and is headquartered in Rancho Dominguez, CA.

Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Part of Nokia Oyj, Xanthon, Inc. develops enterprise software solutions. The company is based in Research Triangle Park, NC. The company was founded by Clay Bernardin Thorp. Xanthon was acquired by Talk2 Technology, Inc. on June 14, 1999.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

American Association for Clinical Chemistry, Inc. (AACC) is a scientific and medical professional organization that focuses on clinical laboratory science and its application to healthcare. The organization is based in Washington and was founded in 1948. AACC provides leadership in education, advocacy, and collaboration to help lab professionals adapt to change and provide vital insight and guidance for patient care. The organization offers accreditation programs, press releases, media advisories, and statements that spotlight scientific, clinical, and technological breakthroughs. AACC has a longstanding commitment to provide customers with the best possible experience every time they use the AACC website. Mark J. Golden has been the CEO of the American company since 2020.

Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London.

bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC.

Stanmore Implants Worldwide, Ltd. designs and manufactures bespoke and modular implants for limb sparing and complex joint replacement. It provides massive endoprothesis tumour systems for orthopedic skeletal locations including the femur, tibia, knee, pelvis and humerus. The firm also offers computer assisted orthopedic surgeries. The company was founded on February 19, 1996 and is headquartered in Elstree, the United Kingdom.

The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry.

GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium.

Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand.

Ieso Digital Health Ltd. provides Internet enabled mental health services to health providers, private individuals and businesses. The firm engages in delivering cognitive behavioral therapy. It offers anxiety, bereavement, child and family, depression, drug and alcohol misuse, eating disorder, managing anger, managing pain, obsessive compulsive disorder, panic, phobia, post traumatic stress, relationship, sexual difficulty, sports psychology, stress management, and terminal illness therapy services. The company was founded by Barnaby Perks, Sue Wright and Nadine Field in 2000 and is headquartered in Cambridge, the United Kingdom.

Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom.

Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel.

Part of Harvard University, Claritas Genomics is a CLIA-certified genetic diagnostic testing company based in Cambridge, MA that combines genetic analysis technology with the clinical expertise of pediatric specialists to improve patient care. The company offers a range of services to support clinicians in diagnosing pediatric disorders. Claritas Genomics also provides drug testing services, including the latest innovation in fingerprint drug testing. The company's President and CEO, Patrice Milos, is a pioneer in genomics and medicine. The company's website includes a list of tests available by name and gene. Samples can be sent to Claritas Genomics for processing, and inquiries can be directed to their email or phone number.

Bantam Pharmaceutical LLC is a privately funded biopharmaceutical company that specializes in the discovery and development of novel therapeutics for difficult-to-treat hematological and solid tumors. The company is based in New York, NY. The company is currently pursuing an IND application for its lead candidate, BTM-3566, in B-cell malignancies. Bantam's clinical development strategy is focused on areas of unmet clinical need, with initial phase I/II clinical trials planned in relapsed/refractory B-cell hematological malignancies, including diffuse large B-cell lymphoma. The company was founded by Victor F. Keen, and Michael T. Stocum has been the CEO of the company since 2019.

BioFluidica, Inc. is a biotechnology company specializing in the development of diagnostic platform for disease management. It captures and isolates disease biomarkers, such as Circulating Tumor Cells. The company was founded by Steven A. Soper in 2007 and is headquartered in San Diego, CA.

Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom.

Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA.

ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.